At The Future of Health Data Summit hosted by Datavant in September 2022 in Washington, D.C., this panel discussed building a global real-world data (RWD) strategy.

Despite high effectiveness of COVID-19 vaccines in the real-world, there have been cases of fully vaccinated patients contracting COVID.

A molecular diagnostics company developed a blood test to support treatment selection for patients with advanced non-small cell lung cancer (NSCLC).

Datavant technology has been vetted and validated through hundreds of security and compliance assessments with the industry’s most stringent organizations.

As a greater number of drugs are distributed through specialty channels, it is difficult to gain deep insights into the patient journey. Single data sources provide limited visibility…

A top 20 pharma company noticed that a significant portion of patients who were on an infusion therapy had stopped treatment. This happened despite patients receiving support through…

A major pharma company had developed a treatment for a rare condition. However, two years after launch, the drug’s sales were far below expectations. Finding eligible patients for…

Address the need for highly accurate privacy-preserving record linkage and patient matching solutions to unlock research and innovation.